Page 108
TEAMKY Demonstration
Approval Period: January 1, 2025 through December 31, 2029
Page 107 of 155 Table 2. Summary of Key Evaluation Questions, Hypotheses, Data Sources, and Analytic Approaches
*Denotes a metric that is also part of the Monitoring Plan Evaluation Question 1: Did access to and utilization of SUD treatment services improve? Demonstration Goal: Increased number of outpatient Medicaid SUD providers, especially those offering medication-assisted treatment (MAT) and methadone as part of MAT, in areas of greatest need. Evaluation Hypothesis: The demonstration will increase the number of outpatient Medicaid SUD providers overall, and those specifically offering MAT and methadone as part of MAT, in areas of greatest need. Driver Measure Description Steward Numerator Denominator Data Sources Analytic Approach
Primary Driver (Increase the number of Medicaid SUD providers, overall and specifically delivering MAT) Providers offering SUD services
N/A Number of providers billing for SUD treatment services Total number of beneficiaries
Claims data
Provider enrollment data
Descriptive statistics
Interrupted time series without comparison group Providers offering MAT N/A Number of providers prescribing any medication that is part of MAT Total number of beneficiaries Providers offering methadone as part of MAT N/A Number of providers prescribing methadone as part of MAT Total number of beneficiaries Providers offering SUD services in areas of greatest need CCBHC 2.a.3 Number of providers billing for SUD treatment services, by county Total number of beneficiaries, by county
Claims data
Provider enrollment data
Descriptive statistics
Providers offering MAT in areas of greatest need CCBHC 2.a.3 Number of providers prescribing any medication that is part of MAT, by county Total number of beneficiaries, by county Providers offering methadone as part of MAT in areas of greatest need CCBHC 2.a.3 Number of providers prescribing methadone as part of MAT, by county Total number of beneficiaries, by county